Tocqueville Asset Management L.P.
Source: SEC Form 13F · as of Mar 2026Tocqueville Asset Management L.P. holds 15 biotech & pharma companies tracked by BioSniper, totaling $54.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$54.0M
BioSniper AIPage evidence connected
Prepared research question
What matters most for IONIS PHARMACEUTICALS INC (IONS)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| IONSIONIS PHARMACEUTICALS INC | 219,220 | $16.5M |
| REGNREGENERON PHARMACEUTICALS, INC. | 15,779 | $12.2M |
| SNYSanofi | 190,498 | $9.2M |
| GILDGILEAD SCIENCES, INC. | 60,817 | $8.5M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 36,757 | $2.0M |
| CSBRCHAMPIONS ONCOLOGY, INC. | 319,674 | $1.8M |
| BBIOBridgeBio Pharma, Inc. | 18,825 | $1.4M |
| IMMXImmix Biopharma, Inc. | 89,550 | $816K |
| AXSMAxsome Therapeutics, Inc. | 4,200 | $710K |
| PCVXVaxcyte, Inc. | 4,200 | $244K |
| ESPREsperion Therapeutics, Inc. | 87,000 | $238K |
| CGTXCOGNITION THERAPEUTICS INC | 195,000 | $148K |
| ONCYONCOLYTICS BIOTECH INC | 149,000 | $126K |
| PBYIPUMA BIOTECHNOLOGY, INC. | 12,960 | $83K |
| DMACDiaMedica Therapeutics Inc. | 10,500 | $71K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.